CME Grou a Aktie 3262089 / US12572Q1058
229.71
USD
2.12
USD
0.93%
21:59:57
BTT
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
CME Group A Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2023 | CME Group Inc (A) | 4.58 | 9.65 | USD |
| 2022 | CME Group Inc (A) | 5.05 | 8.50 | USD |
| 2021 | CME Group Inc (A) | 3.00 | 6.85 | USD |
| 2020 | CME Group Inc (A) | 3.24 | 5.90 | USD |
| 2019 | CME Group Inc (A) | 2.74 | 5.50 | USD |
| 2018 | CME Group Inc (A) | 2.42 | 4.55 | USD |
| 2017 | CME Group Inc (A) | 4.20 | 6.14 | USD |
| 2016 | CME Group Inc (A) | 4.90 | 5.65 | USD |
| 2015 | CME Group Inc (A) | 5.41 | 4.90 | USD |
| 2014 | CME Group Inc (A) | 4.38 | 3.88 | USD |
Gewinn je Aktie- CME Grou a
| 11.9 17 | 5.7 18 | 5.9 19 | 5.9 20 | 7.3 21 | 7.4 22 | 8.9 23 |
Umsatz je Aktie- CME Grou a
| 10.7 17 | 12.8 18 | 13.6 19 | 13.6 20 | 13.1 21 | 14.0 22 | 15.5 23 |
KGV- CME Grou a
| 12.2 17 | 32.9 18 | 34.0 19 | 31.0 20 | 31.3 21 | 22.7 22 | 23.8 23 |
CME Group Inc (A): Die Aktie (in USD)
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie berichtet | 11.94 | 5.71 | 5.91 | 5.87 | 7.29 | 7.40 | 8.86 |
| Gewinn je Aktie unverwässert | 12.00 | 5.73 | 5.93 | 5.88 | 7.30 | 7.41 | 8.87 |
| Gewinn je Aktie verwässert | 11.94 | 5.71 | 5.91 | 5.87 | 7.29 | 7.40 | 8.86 |
| Dividende pro Aktie | 6.14 | 4.55 | 5.50 | 5.90 | 6.85 | 8.50 | 9.65 |
| Gesamtdividendenausschüttung in Mio. | 1’993.50 | 2’149.90 | 1’695.90 | 2’110.00 | 2’189.30 | 2’633.50 | 3’235.50 |
CME Group Inc (A): Unternehmenskennzahlen (in USD)
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Umsatz je Aktie | 10.71 | 12.82 | 13.62 | 13.62 | 13.07 | 13.97 | 15.52 |
| KGV (Jahresendkurs, EPS unverwässert) | 12.23 | 32.95 | 33.97 | 31.00 | 31.33 | 22.73 | 23.77 |
| KGV (Jahresendkurs, EPS verwässert) | 12.23 | 32.95 | 33.97 | 31.00 | 31.33 | 22.73 | 23.77 |
| KGV (Jahresendkurs) | 12.23 | 32.95 | 33.97 | 31.00 | 31.33 | 22.73 | 23.77 |
| Dividendenrendite Jahresende in % | 4.20 | 2.42 | 2.74 | 3.24 | 3.00 | 5.05 | 4.58 |
| Eigenkapitalquote in % | 29.55 | 33.49 | 34.75 | 21.12 | 13.91 | 15.42 | 20.59 |
| Fremdkapitalquote in % | 70.45 | 66.51 | 65.25 | 78.88 | 86.09 | 84.58 | 79.41 |
CME Group Inc (A): GuV (in Mio. USD)
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 3’642.90 | 4’408.00 | 4’880.30 | 4’883.60 | 4’689.70 | 5’019.40 | 5’578.90 |
| Umsatzveränderung in % | 1.30 | 21.00 | 10.71 | 0.07 | -3.97 | 7.03 | 11.15 |
| Bruttoergebnis vom Umsatz | 2’988.70 | 3’705.40 | 3’859.20 | 3’784.50 | 3’723.10 | 4’010.80 | 4’540.40 |
| Bruttoergebnisveränderung in % | 2.84 | 23.98 | 4.15 | -1.94 | -1.62 | 7.73 | 13.20 |
| Operatives Ergebnis | 2’310.20 | 2’643.90 | 2’600.10 | 2’637.40 | 2’645.20 | 3’015.90 | 3’435.70 |
| Veränderung Operatives Ergebnis in % | 9.71 | 14.44 | -1.66 | 1.43 | 0.30 | 14.01 | 13.92 |
| Ergebnis vor Steuern | 2’526.30 | 2’777.80 | 2’689.60 | 2’722.10 | 3’373.60 | 3’490.30 | 4’153.60 |
| Veränderung Ergebnis vor Steuern in % | 10.43 | 9.96 | -3.18 | 1.21 | 23.93 | 3.46 | 19.00 |
| Ergebnis nach Steuer | 4’063.40 | 1’962.20 | 2’116.50 | 2’105.20 | 2’636.10 | 2’696.10 | 3’229.80 |
| Veränderung Ergebnis nach Steuer in % | 164.87 | -51.71 | 7.86 | -0.53 | 25.22 | 2.28 | 19.80 |
CME Group Inc (A): Bilanz (in Mio. USD)
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Gesamtverbindlichkeiten | 53’424 | 51’575 | 49’128 | 98’393 | 169’565 | 147’436 | 103’103 |
| Langzeit Gesamtverbindlichk. pro Aktie | - | - | - | - | - | - | - |
| Eigenkapital | 22’412 | 25’965 | 26’159 | 26’352 | 27’399 | 26’879 | 26’738 |
| Veränderung Eigenkapital in % | 10.18 | 15.65 | 0.81 | 0.73 | 4.10 | -1.90 | -0.52 |
| Bilanzsumme | 75’836 | 77’540 | 75’287 | 124’744 | 196’964 | 174’314 | 129’841 |
| Veränderung Bilanzsumme in % | 9.08 | 2.25 | -2.91 | 65.69 | 57.89 | -11.50 | -25.51 |
CME Group Inc (A): Sonstige Angaben (in USD)
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | 12.00 | 5.73 | 5.93 | 5.88 | 7.30 | 7.41 | 8.87 |
| Veränderung Gewinn je Aktie (unverwässert) in % | 163.74 | -52.25 | 3.42 | -0.70 | 24.12 | 1.43 | 19.78 |
| Gewinn je Aktie (verwässert) | 11.94 | 5.71 | 5.91 | 5.87 | 7.29 | 7.40 | 8.86 |
| Veränderung Gewinn je Aktie (verwässert) in % | 163.58 | -52.18 | 3.47 | -0.61 | 24.18 | 1.46 | 19.78 |
| Anzahl Mitarbeiter | 2’830 | 4’590 | 4’360 | 4’370 | 3’480 | 3’460 | 3’565 |
| Veränderung Anzahl Mitarbeiter in % | 4.81 | 62.19 | -5.01 | 0.23 | -20.37 | -0.57 | 3.03 |
CME Group Inc (A) Termine
| Unternehmen | Event | Datum |
|---|---|---|
| CME Group Inc (A) | Quartalszahlen | 12.02.2025 |
| CME Group Inc (A) | Quartalszahlen | 23.04.2025 |
| CME Group Inc (A) | Quartalszahlen | 23.07.2025 |
| CME Group Inc (A) | Quartalszahlen | 22.10.2025 |
CME Group Inc (A) vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q3 2024 Earnings Release | 23.10.2024 |
| Hauptversammlung | Annual General Meeting | 06.10.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 24.07.2024 |
| Hauptversammlung | Annual General Meeting | 09.05.2024 |
| Quartalszahlen | Q1 2024 Earnings Release | 24.04.2024 |
| Quartalszahlen | Q4 2023 Earnings Release | 14.02.2024 |
| Quartalszahlen | Q3 2023 Earnings Release | 25.10.2023 |
| Quartalszahlen | Q2 2023 Earnings Release | 26.07.2023 |
| Hauptversammlung | Annual General Meeting | 04.05.2023 |
| Quartalszahlen | Q1 2023 Earnings Release | 26.04.2023 |
| Quartalszahlen | Q4 2022 Earnings Release | 08.02.2023 |
| Quartalszahlen | Q3 2022 Earnings Release | 26.10.2022 |
| Quartalszahlen | Q2 2022 Earnings Release | 27.07.2022 |
| Hauptversammlung | Annual General Meeting | 04.05.2022 |
| Quartalszahlen | Q1 2022 Earnings Release | 27.04.2022 |
| Quartalszahlen | Q4 2021 Earnings Release | 09.02.2022 |
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 99.66 |
| The Vanguard Group, Inc. | 9.29 |
| Vanguard Group, Inc. (Subfiler) | 8.96 |
| State Street Corp. | 4.41 |
| Capital Research & Management Co. (World Investors) | 3.37 |
| Vanguard Total Stock Market ETF | 3.17 |
| BlackRock Fund Advisors | 2.89 |
| Vanguard 500 Index Fund | 2.62 |
| BlackRock Institutional Trust Co. NA | 2.33 |
| Geode Capital Management LLC | 2.30 |
| JPMorgan Investment Management, Inc. | 2.12 |
| Morgan Stanley Investment Management Ltd. | 1.54 |
| American Funds Income Fund of America | 1.52 |
| Norges Bank (13F) | 1.34 |
| Columbia Management Investment Advisers LLC | 1.30 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 4’360 | 4’370 | 3’480 | 3’460 | 3’565 |
| Umsatz pro Mitarbeiter in Mio. EUR | 1.12 | 1.12 | 1.35 | 1.45 | 1.56 |
Bilanz (in Mio. USD) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 0 | 0 | 0 | 0 | 0 |
| Summe Anlagevermögen | 0 | 0 | 0 | 0 | 0 |
| Summe Aktiva | 75’287 | 124’744 | 196’964 | 174’314 | 129’841 |
Bilanz (in Mio. USD) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 4’399 | 4’072 | 4’026 | 3’948 | 3’884 |
| Summe Fremdkapital | 49’128 | 98’393 | 169’565 | 147’436 | 103’103 |
| Summe Eigenkapital | 26’159 | 26’352 | 27’399 | 26’879 | 26’738 |
| Summe Passiva | 75’287 | 124’744 | 196’964 | 174’314 | 129’841 |
Adresse
| 20 South Wacker Drive, 60606 Chicago | |
| Telefon | +1 (312) 930-1000 |
| Fax | +1 (312) 466-4410 |
| URL | http://www.cmegroup.com |
Management
|
Adrienne Hilary Seaman
Managing Director & Head-EMEA Legal |
|
Anita S. Liskey
Senior Managing Director-Global Brand Marketing |
|
Bryan Thomas Durkin
Director |
|
Charles Peter Carey
Independent Director |
|
Daniel G. Kaye
Independent Director |
|
Daniel Robert Glickman
Independent Director |
|
David M. Wong
Director-Cross Asset Strategy & Planning |
|
Deborah Jean Lucas
Independent Director |
|
Dennis A. Suskind
Lead Independent Director |
|
Derek L. Sammann
Senior MD & Global Head-Commodity & Options |
|
Elizabeth A. Cook
Independent Director |
|
Harold E. Ford
Director |
|
Hilda Harris Piell
Chief Human Resources Officer & Senior MD |
|
Howard J. Siegel
Independent Director |
|
Jack J. Tobin
Chief Accounting Officer & Managing Director |
|
Jonathan Marcus
Senior Managing Director & General Counsel |
|
Julie M. Winkler
Chief Commercial Officer |
|
Kathryn Benesh
Director |
|
Kendal Vroman
Chief Transformation Officer |
|
Larry G. Gerdes
Independent Director |
|
Lynne Fitzpatrick
President & Chief Financial Officer |
|
Margaret A. Wright
Secretary |
|
Martin J. Gepsman
Independent Director |
|
Michael Adam Sonnenshein
Member-Bitcoin Futures Council |
|
Michael G. Dennis
Global Head-Fixed Income |
|
Patrick J. Mulchrone
Independent Director |
|
Patrick W. Maloney
Independent Director |
|
Paul Houston
Executive Director & Head-FX Division |
|
Peter Keavey
MD & Global Head, Crude & Refined Energy Products |
|
Phyllis M. Lockett
Independent Director |
|
Rahael Seifu
Independent Director |
|
Robert J. Tierney
Independent Director |
|
Sunil Cutinho
Chief Information Officer |
|
Suzanne Sprague
Chief Operating Officer & Global Head-Clearing |
|
Terrence A. Duffy
Executive Chairman & Chief Executive Officer |
|
Terry L. Savage
Independent Director |
|
Tim McCourt
Senior MD, Global Head-Financial & OTC Products |
|
Timothy S. Bitsberger
Independent Director |
|
Trey Berre
Global Head-Data Services |
|
Wesley Lee Betsill
Chief Risk Officer |
|
William R. Shepard
Independent Director |
|
William W. Hobert
Independent Director |